Michihiro Mieda

Michihiro Mieda

Auto-generated profile, based on publicly available information

Michihiro Mieda

Department of Integrative Neurophysiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-8640, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Neuron
Verified
Journal Article
Closed access
AYAkihiro Yamanaka
Akihiro Yamanaka
CBCarsten T Beuckmann
Carsten T Beuckmann
JWJon T Willie
Jon T Willie
JHJunko Hara
Junko Hara
NTNatsuko Tsujino
Natsuko Tsujino
TSTakeshi Sakurai
Takeshi Sakurai

1 April 2017 in Current Biology
Verified
Journal Article
Closed access
CTChak Foon Tso
Chak Foon Tso
TSTatiana Simon
Tatiana Simon
AGAlison C. Greenlaw
Alison C. Greenlaw
TPTanvi Puri
Tanvi Puri
MMMichihiro Mieda
Michihiro Mieda
EHErik D. Herzog
Erik D. Herzog

27 April 2011 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MMMichihiro Mieda
Michihiro Mieda
EHEmi Hasegawa
Emi Hasegawa
YKYaz Y. Kisanuki
Yaz Y. Kisanuki
CSChristopher M. Sinton
Christopher M. Sinton
MYMasashi Yanagisawa
Masashi Yanagisawa
TSTakeshi Sakurai
Takeshi Sakurai
Orexin-A and orexin-B are hypothalamic neuropeptides that play critical roles in the maintenance of wakefulness. Intracerebroventricular (ICV) administration of orexin-A has been shown to promote wakefulness and suppress both rapid eye movement (REM) sleep and non-REM (NREM) sleep through the orexin receptor-1 (OX1R) and orexin receptor-2 (OX2R). Here, we elucidated the differential roles of orexin receptors in the regulation of sleep and wakefulness by comparing the effects of ICV orexin-A administration in wild-type,OX1R−/−, andOX2R−/−mice. The effects of orexin-A on wakefulness and NREM sleep were significantly attenuated in both knock-out mice as compared with wild-type mice, with substantially larger attenuation inOX2R−/−mice than inOX1R−/−mice. These results suggest that although the OX2R-mediated pathway has a pivotal role in the promotion of wakefulness, OX1R also plays additional roles in promoting arousal. In contrast, suppression of REM sleep by orexin-A administration was slightly and similarly attenuated in bothOX1R−/−andOX2R−/−mice, suggesting a comparable contribution of the two receptors to REM sleep suppression. Histological studies demonstrated differential distributions of each receptor subtype in distinct neuronal populations with specific neurotransmitter identities in brainstem cholinergic/monoaminergic neurons. In the laterodorsal tegmental and pedunculopontine tegmental nuclei especially, cholinergic neurons exclusively expressedOX1RmRNA, butOX2RmRNA was expressed mainly in GABAergic putative interneurons. Thus, each orexin receptor subtype plays differential roles in gating NREM and REM sleep through distinct neuronal pathways.

1 March 2015 in Neuron
Verified
Journal Article
Closed access
MMMichihiro Mieda
Michihiro Mieda
DODaisuke Ono
Daisuke Ono
EHEmi Hasegawa
Emi Hasegawa
HOHitoshi Okamoto
Hitoshi Okamoto
KHKen-Ichi Honma
Ken-Ichi Honma
TSTakeshi Sakurai
Takeshi Sakurai

27 May 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKoh Sasaki
Koh Sasaki
MSMika Suzuki
Mika Suzuki
MMMichihiro Mieda
Michihiro Mieda
NTNatsuko Tsujino
Natsuko Tsujino
BRBryan Roth
Bryan Roth
TSTakeshi Sakurai
Takeshi Sakurai
Hypothalamic neurons expressing neuropeptide orexins are critically involved in the control of sleep and wakefulness. Although the activity of orexin neurons is thought to be influenced by various neuronal input as well as humoral factors, the direct consequences of changes in the activity of these neurons in an intact animal are largely unknown. We therefore examined the effects of orexin neuron-specific pharmacogenetic modulation in vivo by a new method called the Designer Receptors Exclusively Activated by Designer Drugs approach (DREADD). Using this system, we successfully activated and suppressed orexin neurons as measured by Fos staining. EEG and EMG recordings suggested that excitation of orexin neurons significantly increased the amount of time spent in wakefulness and decreased both non-rapid eye movement (NREM) and rapid eye movement (REM) sleep times. Inhibition of orexin neurons decreased wakefulness time and increased NREM sleep time. These findings clearly show that changes in the activity of orexin neurons can alter the behavioral state of animals and also validate this novel approach for manipulating neuronal activity in awake, freely-moving animals.

6 July 2010 in Annals of the New York Academy of Sciences
Verified
Journal Article
Open access
PDF file
TSTakeshi Sakurai
Takeshi Sakurai
MMMichihiro Mieda
Michihiro Mieda
NTNatsuko Tsujino
Natsuko Tsujino
The neuropeptides orexin A and orexin B, produced in hypothalamic neurons, are critical regulators of sleep/wake states. Deficiency of orexin signaling results in narcoleptic phenotype in humans, dogs, and rodents. Recently, accumulating evidence has indicated that the orexin system regulates sleep and wakefulness through interactions with neuronal systems that are closely related with emotion, reward, and energy homeostasis. In this review, we will discuss the current understanding of the physiology of the orexin system especially focusing on its roles in the regulation of sleep/wakefulness states.